Abstract: The present disclosure relates to a method for providing information for determining lung tumor through inhalation of a fluorescent contrast agent, more particularly to a method of inhaling a small amount of Indocyanine green. The present disclosure does not have the problem of the existing intravenous injection that the administered fluorescent contrast agent is distributed throughout the body. In addition, when comparing the cancer detection efficiency of inhalation administration and intravenous injection, the inhaled fluorescent contrast agent exhibits remarkably higher cancer detection effect than the intravenously injected fluorescent contrast agent.

Abstract: The present invention relates to an X-ray imaging device for minimally invasive surgery, the device including: a rod having a clamp module disposed at a first end of the rod and including a first clamp body, a second clamp body, and a clamp support; an X-ray emission module; an X-ray sensing module; and a manipulation module, in which the rod is inserted into the human body, X-rays are emitted from the X-ray emission module with the first end of the first clamp body and the first end of the second clamp body open with a lesion positioned therebetween in the human body, and the X-rays travel through the lesion and is then sensed by the X-ray sensing module.

Abstract: The present invention relates to an X-ray imaging device for minimally invasive surgery, the device including: a rod having a clamp module disposed at a first end of the rod and including a first clamp body, a second clamp body, and a clamp support; an X-ray emission module; an X-ray sensing module; and a manipulation module, in which the rod is inserted into the human body, X-rays are emitted from the X-ray emission module with the first end of the first clamp body and the first end of the second clamp body open with a lesion positioned therebetween in the human body, and the X-rays travel through the lesion and is then sensed by the X-ray sensing module.

Abstract: Provided according to one embodiment of the present invention is a marker composition for diagnosis or prognosis of esophageal cancer or thymic carcinoma, comprising an exosome overexpressing GRIP and coiled-coil domain-containing protein 2 (GCC2).

Abstract: The present invention relates to a chest tube insertion device using an endoscopic guide, the device having a structure comprising: a tube insertion guide body which is made from a transparent or semitransparent synthetic resin material and which is introduced into the thoracic cavity of the human body while being flexibly bendable, an endoscopic tube disposed inside the tube insertion guide body; a chest tube formed as a structure for encompassing the outer side of the tube insertion guide body, so as to be spaced from the endoscopic tube; a guide holder for performing an endoscopic guide function and a tube insertion guide body fixing function when the tube insertion guide body is inserted into the thoracic cavity; and a handle part to which the guide holder is separably coupled.

Abstract: According to an aspect of embodiments, a method of generating an image by using LiDAR includes performing a reconstruction of a two-dimensional reflection intensity image, the performing of the reconstruction including projecting three-dimensional reflection intensity data that are measured by using the LiDAR as the two-dimensional reflection intensity image, and the method includes generating a color image by applying a projected two-dimensional reflection intensity image to a Fully Convolutional Network (FCN).

Abstract: A risk determining method and apparatus are disclosed. The risk determining method includes obtaining a plurality of sets of elevation-velocity data, determining a diffusion prediction coefficient based on the obtained sets of elevation-velocity data, determining at least one of a volatilization factor (VF) or a particulate emission factor (PEF) based on the determined diffusion prediction coefficient, and determining a risk from an inhalation exposure based on the at least one of the VF or the PEF.

Abstract: According to an embodiment of the present invention, a composition for diagnosing or predicting the prognosis of lung cancer is provided, the composition including a primer, probe, or antibody that specifically binds to a GRIP and coiled-coil domain-containing protein (GCC2) gene or protein in an exosome.

Abstract: According to an embodiment of the present disclosure, there is provided a marker composition for diagnosing cancer or predicting prognosis, comprising exosomes overexpressing a Tubulin alpha-1C chain (TUBA1C) protein.

Abstract: According to an aspect of embodiments, a method of generating an image by using LiDAR includes performing a reconstruction of a two-dimensional reflection intensity image, the performing of the reconstruction including projecting three-dimensional reflection intensity data that are measured by using the LiDAR as the two-dimensional reflection intensity image, and the method includes generating a color image by applying a projected two-dimensional reflection intensity image to a Fully Convolutional Network (FCN).

Abstract: A risk determining method and apparatus are disclosed. The risk determining method includes obtaining a plurality of sets of elevation-velocity data, determining a diffusion prediction coefficient based on the obtained sets of elevation-velocity data, determining at least one of a volatilization factor (VF) or a particulate emission factor (PEF) based on the determined diffusion prediction coefficient, and determining a risk from an inhalation exposure based on the at least one of the VF or the PEF.

Abstract: The present disclosure relates to exhalation-based lung cancer diagnosis method and system.

Abstract: The present invention relates to a pulmonary surfactant-based anticancer drug. The anticancer drug encapsulated in a liposome made of a pulmonary surfactant can effectively target lung cancer cells, especially adenocarcinomas derived from type II alveolar cells, and has low toxicity and excellent structural stability.

Abstract: Described herein is a composition for diagnosing or predicting the prognosis of lung cancer. The composition includes a primer, probe, or antibody that specifically binds to a GRIP and coiled-coil domain-containing protein (GCC2) gene or protein in an exosome.

Abstract: A data storage device for reducing a firmware update time includes a non-volatile memory configured to store a firmware update image which will replace a current firmware image, a first volatile memory, and a processor configured to control an operation of the non-volatile memory and an operation of the first volatile memory. When a first code included in the current firmware image is executed by the processor, the first code generates data necessary for an operation of the data storage device and stores the data in the first volatile memory. When a second code included in the firmware update image is executed by the first code, the second code accesses and uses the data that has been stored in the first volatile memory.

Abstract: The present invention relates to a multi-column for isolating exosomes and an exosome isolation method, for isolating exosomes from a biological sample containing exosomes mixed with impurities such as lipoproteins and water-soluble proteins.

Abstract: The present disclosure relates to a method for providing information for determining lung tumor through inhalation of a fluorescent contrast agent, more particularly to a method of inhaling a small amount of Indocyanine green. The present disclosure does not have the problem of the existing intravenous injection that the administered fluorescent contrast agent is distributed throughout the body. In addition, when comparing the cancer detection efficiency of inhalation administration and intravenous injection, the inhaled fluorescent contrast agent exhibits remarkably higher cancer detection effect than the intravenously injected fluorescent contrast agent.

Abstract: The present invention relates to an X-ray imaging device for minimally invasive surgery, the device including: a rod having a clamp module disposed at a first end of the rod and including a first clamp body, a second clamp body, and a clamp support; an X-ray emission module; an X-ray sensing module; and a manipulation module, in which the rod is inserted into the human body, X-rays are emitted from the X-ray emission module with the first end of the first clamp body and the first end of the second clamp body open with a lesion positioned therebetween in the human body, and the X-rays travel through the lesion and is then sensed by the X-ray sensing module.

Abstract: The present invention relates to a complex prepared by conjugating indocyanine green to mannosyl serum albumin in order to overcome shortcomings such as low light stability and low in vivo stability of indocyanine green that is a fluorescent dye reagent that is used during surgical operations, a preparation method thereof, an optical imaging probe comprising the same, and a kit comprising the probe.

Abstract: A data storage device for reducing a firmware update time includes a non-volatile memory configured to store a firmware update image which will replace a current firmware image, a first volatile memory, and a processor configured to control an operation of the non-volatile memory and an operation of the first volatile memory. When a first code included in the current firmware image is executed by the processor, the first code generates data necessary for an operation of the data storage device and stores the data in the first volatile memory. When a second code included in the firmware update image is executed by the first code, the second code accesses and uses the data that has been stored in the first volatile memory.